<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000322131"><TermName>alanosine</TermName><TermPronunciation>(uh-LAN-oh-seen)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called antimetabolites. Also called SDX-102.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731184" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;alanosine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731185" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;alanosina&quot;" language="es" id="_4"/><SpanishTermName>alanosina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de antimetabolito. También se llama SDX-102.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-07-26</DateFirstPublished></GlossaryTerm>
